Actusnews Wire - Professional broadcaster of corporate and regulated information, authorised by the AMF and the CSSF.

  FERMENTALG company press release from 05/02/2018

  05/02/2018 - 18:00

Fermentalg strengthens its technological lead with the acquisition of a strategic portfolio of patents for Omega 3 production

Libourne – 5 February 2018 – Fermentalg (Euronext – FALG), French leader in microalgae for nutrition and health, has announced the acquisition of a portfolio of patents to reinforce its intellectual property and industrial and commercial capabilities in its strategic market of Omega 3 production.

Fermentalg now owns a portfolio of five patents, some of which have already been issued in several countries, to add to its 21 families of active patents already filed. The Group has also acquired a number of microalgae strains to add to its 2000+ strain bank which is one of the largest in the world.

This intellectual property opens the way for new opportunities in Omega 3 production, particularly oils rich in essential fatty acids and natural pigments which are the two major product families developed by the company, both directly or indirectly through partnerships.

Hywel Griffiths, Chief Scientific Officer for Fermentalg, said: “As soon as we saw the opportunity to acquire this technological expertise, we knew it would give us the competitive advantage needed to offer innovative products with a very high value-added to industry partners in our strategic markets of nutrition and health. It is an acquisition that once again reflects Fermentalg's position as a driver of innovation through the bio-industrial exploitation of microalgae.”

All sources combined (EPA, DHA, etc.), today's Omega 3 market is estimated at $1.4 billion, with markets in Asia-Pacific, the United States, Latin America and Europe. Estimated at around 2,000 tons per year, the market for DHA derived from microalgae has enjoyed robust growth over the last few years thanks to changing consumption patterns.

At the end of 2017, Fermentalg announced the signing of a Europe-wide distribution agreement with IMCD Group, a leader in the sales, marketing and distribution of speciality chemicals and food ingredients. The agreement includes DHA350, an Omega-3-rich algal oil unveiled at VITAFOODS EUROPE, and DHA550, an oil offering a high concentration of Omega 3 scheduled for launch in the first half of 2018.

About Fermentalg

Fermentalg is a French leader in microalgae. Based in Libourne (Nouvelle Aquitaine), the company produces oils, pigments and proteins through the bio-industrial exploitation of microalgae. Its primary markets are the human nutrition and animal feed sectors as well as the health industry. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at:



Press Relations: Investor Relations:
ACTUS finance & communication
Alexandra Prisa
Tel: +33 (0)1 53 67 36 90
ACTUS finance & communication
Jérôme Fabreguettes-Leib
Tel: +33 (0)1 53 67 36 78